Training facilities are increasingly vital in transfer talks, meaning clubs are spending millions in a bid to gain an edge ...

Premier League champions Liverpool take on Eintracht Frankfurt in the Champions League and new customers joining Betfair can ...

Bayer boss Werner Baumann's contract has been extended until 2024, in a show of support from the drugmaker's new chairman just months after the company agreed an $11 billion outline settlement of U.S.

The U.S. Environmental Protection Agency said on Tuesday it will allow farmers to spray crops with weed killers based on the chemical dicamba that are sold by Bayer AG and other companies, after a U.S ...

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan for the group starts to deliver results. Just over two years into Anderson's tenure, ...

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia has won FDA approval for a new heart failure indication thought to be pivotal for the product's sales prospects. The US regulator has ...

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Microsoft MSFT-0.03%decrease; red down pointing triangle Chief Executive Satya Nadella is handing off some responsibilities, citing a need to focus on the company’s biggest artificial-intelligence ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

The International Space Station (ISS) is one of humanity’s greatest achievements, providing a habitat in orbit that has been occupied continuously for almost 25 years. Visited by almost 300 people ...

Video on demand, TV streaming, multimedia. Hand holding remote control Netflix, Disney+ and the other major streamers will have to dial down the volume on their commercials in California after ...

After nearly two decades in the endocrine scene, Crinetics is making its commercial debut with the approval of a game-changing treatment for the rare growth disorder acromegaly. The FDA on Thursday ...